Abstract
Background
Iron-deficiency anemia (IDA) is a common clinical condition and may be caused by gastrointestinal blood loss. Gastrointestinal lesions, including inflammatory diseases, polyps, and malignancies, may be clinically silent. This study evaluated the gastrointestinal endoscopic findings in men older than 40 years and postmenopausal women with IDA.
Methods
This cross-sectional study was conducted at Imam Khomeini Hospital, Ardabil, Iran, between January 2019 and January 2020. Men older than 40 years and postmenopausal women with laboratory findings compatible with IDA were included. Demographic characteristics, clinical symptoms, laboratory findings, and upper and lower gastrointestinal endoscopic findings were recorded. The frequency of gastrointestinal lesions was determined, and associations between gastrointestinal symptoms and endoscopic findings were evaluated.
Results
A total of 480 patients were included. According to the reported study data, 264 patients were men and 216 were women. Upper gastrointestinal endoscopy was performed in 286 patients and colonoscopy in 194 patients. Upper gastrointestinal lesions were reported in 168 patients (35%), while colonic polyps and colorectal cancer were reported in 28 (5.83%) and 20 (4.17%) patients, respectively. A gastrointestinal cause of IDA was not identified in 262 patients (54.58%). Upper gastrointestinal symptoms were significantly associated with positive upper gastrointestinal endoscopic findings (OR=9.56, 95% CI: 4.83–19.18; P=0.0001), and lower gastrointestinal symptoms were significantly associated with positive colonoscopic findings (OR=4.02, 95% CI: 1.54–10.47; P=0.001). Hemoglobin and ferritin levels were not significantly associated with gastrointestinal malignancy.
Conclusion
Gastrointestinal endoscopy identified a broad spectrum of lesions in patients with IDA, including clinically important malignant lesions. Gastrointestinal symptoms were associated with positive endoscopic findings; however, the absence of symptoms should not necessarily exclude significant gastrointestinal pathology.
References 9
-
1. Bathla S, Arora S. Prevalence and approaches to manage iron deficiency anemia (IDA). Critical Re-views in Food Science and Nutrition. 2022;62(32):8815-28.
-
2. Leung AK, Lam JM, Wong AH, Hon KL, Li X. Iron deficiency anemia: an updated review. Current pedi-atric reviews. 2024;20(3):339-56.
-
3. DeLoughery TG, Jackson CS, Ko CW, Rockey DC. AGA clinical practice update on management of iron deficiency anemia: expert review. Clinical Gastroen-terology and Hepatology. 2024;22(8):1575-83.
-
4. Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D, et al. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. Hemasphere. 2024;8(7): e108.
-
5. Weyand AC, Chaitoff A, Freed GL, Sholzberg M, Choi SW, McGann PT. Prevalence of iron deficiency and iron-deficiency anemia in US females aged 12-21 years, 2003-2020. Jama. 2023;329(24):2191-3.
-
6. Cappellini MD, Santini V, Braxs C, Shander A. Iron metabolism and iron deficiency anemia in women. Fertility and sterility. 2022;118(4):607-14.
-
7. Auerbach M, DeLoughery TG, Tirnauer JS. Iron de-ficiency in adults: a review. Jama. 2025;333(20):1813-23.
-
8. Nandakumar S, Singh N, Tharani AR, Pankiw M, Brezden-Masley C. Intravenous iron and iron defi-ciency anemia in patients with gastrointestinal can-cer: A systematic review. PLoS One. 2024;19(5): e0302964.
-
9. Dadvand A, Nooroulahi M, Matin S, Faghfuri E. Harnessing the chimeric antigen receptor engineered cells in gastrointestinal cancer immunotherapy. In-ternational Immunopharmacology. 2025; 164:115321.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Nastaran Sadeghi Fard, Nazli Javaheri, Aryan Ghalandari (Author)